Optimal medical therapy for secondary prevention after an acute coronary syndrome: 18-month follow-up results at a tertiary teaching hospital in South Korea

BACKGROUND: Acute coronary syndrome (ACS) is a fatal cardiovascular disease caused by atherosclerotic plaque erosion or rupture and formation of coronary thrombus. The latest guidelines for ACS recommend the combined drug regimen, comprising aspirin, P2Y(12) inhibitor, angiotensin-converting enzyme...

Descripción completa

Detalles Bibliográficos
Autores principales: Byeon, Hee Ja, Yang, Young-Mo, Choi, Eun Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758787/
https://www.ncbi.nlm.nih.gov/pubmed/26929629
http://dx.doi.org/10.2147/TCRM.S99869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758787/
https://www.ncbi.nlm.nih.gov/pubmed/26929629
http://dx.doi.org/10.2147/TCRM.S99869

Ejemplares similares